Furthermore, the same group revealed a novel mechanism in which TGF-β, a cytokine released by both cancer and immune cells, could induce miR-181a and miR-181b at the post-transcriptional level, subsequently leading to ATM down-regulation and enhancing the sphere-initiating stem cell-like features in breast cancer cells [50]. Here, ATM is linked to breast carcinoma.